Table 7. Pharmacogenetics testing.
Characteristic | No. (%) | |
---|---|---|
Mandatory testing before prescribing (n = 12) | ||
None of the drugs below | 7 (58.3) | |
HLA-B*1502 (carbamazepine) | 3 (25.0) | |
HLA-B*5701 (abacavir) | 2 (16.7) | |
HLA-B*5801 (allopurinol) | 1 (8.3) | |
Recommended testing before prescribing (n = 11) | ||
None of the drugs below | 5 (45.5) | |
HLA-B*5801 (allopurinol) | 4 (36.4) | |
HLA-B*1502 (carbamazepine) | 3 (27.3) | |
HLA-B*5701 (abacavir) | 0 (0) |
HLA, human leukocyte antigen.